Glass Fiber-Supported Hybrid Monolithic Spin Tip for Enrichment of Phosphopeptides from Urinary Extracellular Vesicles

Haiyang Zhang,Yuanyuan Deng,Xinyi Liu,Jie Sun,Leyao Ma,Yajie Ding,Zhen Zhan,Hao Zhang,Yuchen Yang,Yanhong Gu,Anton B. Iliuk,Chenxi Yang,W. Andy Tao
DOI: https://doi.org/10.1021/acs.analchem.0c03557
IF: 7.4
2020-10-19
Analytical Chemistry
Abstract:Extracellular vesicles (EVs) are attracting increasing interest with their intriguing role in intercellular communications. Protein phosphorylation in EVs is of great importance for understanding intercellular signaling processes. However, the study of EV phosphoproteomics is impeded by their relatively low amount in limited clinical sample volumes, and it is necessary to have a sensitive and efficient enrichment method for EV phosphopeptides. Herein, a novel Ti(IV)-functionalized and glass fiber-supported hybrid monolithic spin tip, termed PhosTip, was prepared for enriching phosphopeptides from urinary EVs. Glass fiber as the stationary phase positions the hybrid monolith in a standard pipet tip and prevents the monolith from distortion during experiments. The preparation procedure for the new PhosTip is simple and time-saving. The hybrid monolithic PhosTip provides excellent enrichment efficiency of low-abundance phosphopeptides from cell digests and urinary EVs with minimum contamination and sample loss. Using the PhosTip, we demonstrate that 5373 and 336 unique phosphopeptides were identified from 100 and 1 μg of cell lysates, while 3919 and 217 unique phosphopeptides were successfully identified from 10 and 1 mL of urinary samples, respectively. The PhosTip was finally applied to enrich phosphopeptides in urine EVs from prostate cancer patients and healthy controls and quantify 118 up-regulated proteins with phosphosites in prostate cancer samples. These results demonstrated that the PhosTip could be a simple and convenient tool for enriching phosphopeptides from clinical samples and for broader applications in biomarker discovery.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c03557?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c03557</a>.Additional experimental methods, characterization results of hybrid monoliths, Western blot analysis of CD9 in urinary EVs, numbers of identified EVs phosphopeptides enriched by TiO<sub>2</sub>, overlap of identified unique phosphopeptides enriched from different volumes of urinary EV samples, and protein network analysis of up-regulated phosphoproteins in the prostate cancer group obtained from STRING (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c03557/suppl_file/ac0c03557_si_001.pdf">PDF</a>)LC–MS phosphoproteomics data for different sample volumes and quantitative phosphoproteomics results of LC–MS analysis for healthy control and prostate cancer samples (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c03557/suppl_file/ac0c03557_si_002.xlsx">XLSX</a>)This article has not yet been cited by other publications.
chemistry, analytical
What problem does this paper attempt to address?